ODYY Company Profile and Key Details

The stock is currently mid-range between its 52-week high and low $0.00 and $0.12. With a market capitalization of about $1.01 million, Odyssey Health, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-1.39). Key stats such as the average daily volume over the past year has been around 122.11 thousand shares, volume is running light vs its 52-week average. Headquartered in Las Vegas, NV, Odyssey Health, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Joseph Michael Redmond, the company employs approximately 2 people and listed since January 08, 2021. Odyssey Health, Inc. operates as a medical enterprise, primarily focused on the innovation and development of diverse healthcare products.

Average 10-day trading volume of 105.98 thousand shares is below the 3-month average of 144.14 thousand, indicating normal recent market interest.

Odyssey Health, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.02. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Odyssey Group International, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Odyssey Group International, Inc. trading at a premium to the broader market with a P/E of -0.27.

Odyssey Group International, Inc. trades at a P/E ratio of -0.27, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of -0.1 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.97, also below market averages.